Solid-phase synthesis made routine peptide production possible by keeping the growing chain attached to a resin while reagents are washed past it in excess.
Key Takeaways
- The C-terminal residue is anchored to an insoluble polymer support, and each cycle couples the next protected amino acid and then removes its temporary protecting group.
- Each residue requires deprotection, washing, coupling, washing, and usually a capping step to acetylate unreacted chains.
- Global deprotection and cleavage release the peptide from the support, after which the crude material is purified, usually by preparative reversed-phase HPLC.
The core idea
The C-terminal residue is anchored to an insoluble polymer support, and each cycle couples the next protected amino acid and then removes its temporary protecting group. Because the chain stays bound, excess reagent drives each coupling to completion and impurities are removed by simple filtration.
Why excess reagent works
Solution-phase chemistry requires stoichiometric control at every step. On solid phase, a large excess of activated amino acid can be used and then washed away, which is what makes the process fast enough to automate and reliable enough to run unattended.
For related mechanism work, see Fmoc vs Boc synthesis.
The cycle in practice
Each residue requires deprotection, washing, coupling, washing, and usually a capping step to acetylate unreacted chains. Capping is what prevents deletion sequences from accumulating, and it is frequently omitted in protocols that later show puzzling impurities.
Why long sequences are hard
Incomplete coupling and aggregation of the growing chain on the resin both worsen with length. Aggregation is sequence-dependent and is the main reason some targets fail while others of similar length succeed.
What happens at the end
Global deprotection and cleavage release the peptide from the support, after which the crude material is purified, usually by preparative reversed-phase HPLC. Crude purity falls with length, so purification yield is the practical limit on cost.
Experimental Conditions and Practical Setup
A standard cycle deprotects with a piperidine solution in dimethylformamide, washes, couples with an excess of activated amino acid, washes again, and caps unreacted chains. Coupling completion is checked by a colour test on a few beads, and a negative result triggers a second coupling before the next residue is added.
Typical Fmoc cycle parameters
| Step | Reagent | Purpose |
|---|---|---|
| Deprotection | Piperidine in DMF | Remove the Fmoc group |
| Coupling | Activated protected amino acid, excess | Form the amide bond |
| Capping | Acetic anhydride with base | Block unreacted chains |
| Wash | DMF, then dichloromethane | Remove reagents and byproducts |
| Monitoring | Colour test on beads | Confirm coupling completion |
Practical Notes for the Bench
- Always include a capping step to prevent deletion sequence buildup.
- Expect on-resin aggregation to be the dominant failure mode for long or hydrophobic targets.
- Treat crude purity as the main driver of final cost.
Frequently Asked Questions
Why is the peptide attached to a resin?
Because it lets each coupling be driven with excess reagent and impurities removed by filtration rather than by isolating intermediates.
What is capping for?
It acetylates unreacted chains so they cannot extend further, preventing deletion sequences from contaminating the product.
Why do some sequences fail entirely?
Most often on-resin aggregation of the growing chain, which blocks further coupling and is strongly sequence-dependent.
Why is capping included if coupling is efficient?
Because any unreacted chain that survives will be extended later, producing a deletion sequence that is often difficult to separate from the target peptide.
Related Reading
- Fmoc vs Boc synthesis
- native chemical ligation
- peptide cleavage deprotection
- bacteriocin peptides
- peptide waste disposal
References & Further Reading
- Winkler DFH et al. Automated Solid-Phase Peptide Synthesis. Methods Mol Biol. 2020. PubMed 31879919
- Noki S et al. Safety-Catch Linkers for Solid-Phase Peptide Synthesis. Molecules. 2024. PubMed 38611709
- Merrifield RB et al. Solid-phase peptide synthesis. Adv Enzymol Relat Areas Mol Biol. 1969. PubMed 4307033
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- USP general chapters on pharmaceutical analysis
This article summarises published research practice for laboratory professionals. It is not a guide to human use, and no claim of therapeutic benefit is made or implied.
Reviewed by Dr. Elena Marchetti, Peptide Chemistry & Analytical Characterization.